<DOC>
	<DOCNO>NCT00051844</DOCNO>
	<brief_summary>This 48 week study intend HIV Infected person whose first treatment regimen nonnucleoside reverse transcriptase inhibitor ( NNRTI ) fail regimen . They must currently fail regimen eligible .</brief_summary>
	<brief_title>Capravirine ( AG1549 ) Combination With Viracept Two NRTIs HIV Infected Patients Who Failed Initial NNRTI Containing Regimen</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Male female least 18 year old HIV RNA level &gt; 1000 copies/mL screen CD4 &gt; 50 cells/uL screen Patient currently take regimen include NNRTI plus 2 NRTIs least 28 day currently fail regimen Patient adequate hematology test ( absolute neutrophil count &gt; 1000/uL , Platelets &gt; 75,000uL , hemoglobin 9g/L ) Patient adequate renal function ( serum creatinine &lt; 1.5 upper limit normal ) Patient adequate liver function ( AST , ALT , bilirubin &lt; 2.5 upper limit normal ) Previous use protease inhibitor ( except patient short duration PI switch tolerability reason viral load &lt; 50 copy ) This exception include Viracept Women pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>HIV</keyword>
	<keyword>NNRTI Failure</keyword>
	<keyword>HIV Infections</keyword>
</DOC>